Annual FCF
-$139.21 M
+$8.36 M+5.66%
December 31, 2023
Summary
- As of February 12, 2025, PHAT annual free cash flow is -$139.21 million, with the most recent change of +$8.36 million (+5.66%) on December 31, 2023.
- During the last 3 years, PHAT annual FCF has fallen by -$68.49 million (-96.83%).
- PHAT annual FCF is now -13508.41% below its all-time high of -$1.02 million, reached on December 31, 2018.
Performance
PHAT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$63.62 M
+$7.15 M+10.10%
September 30, 2024
Summary
- As of February 12, 2025, PHAT quarterly free cash flow is -$63.62 million, with the most recent change of +$7.15 million (+10.10%) on September 30, 2024.
- Over the past year, PHAT quarterly FCF has increased by +$7.15 million (+10.10%).
- PHAT quarterly FCF is now -7783.15% below its all-time high of -$807.00 thousand, reached on March 31, 2019.
Performance
PHAT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$247.72 M
-$30.76 M-14.18%
September 30, 2024
Summary
- As of February 12, 2025, PHAT TTM free cash flow is -$247.72 million, with the most recent change of -$30.76 million (-14.18%) on September 30, 2024.
- Over the past year, PHAT TTM FCF has dropped by -$30.76 million (-14.18%).
- PHAT TTM FCF is now -30595.91% below its all-time high of -$807.00 thousand, reached on March 31, 2019.
Performance
PHAT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
PHAT Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.7% | +10.1% | -14.2% |
| 3 y3 years | -96.8% | -53.5% | -67.9% |
| 5 y5 years | -10000.0% | -53.5% | -67.9% |
PHAT Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +6.4% | -186.5% | +10.1% | -81.6% | at low |
| 5 y | 5-year | -125.4% | +6.4% | -576.7% | +10.1% | -375.3% | at low |
| alltime | all time | <-9999.0% | +6.4% | -7783.1% | +10.1% | <-9999.0% | at low |
Phathom Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$63.62 M(-10.1%) | -$247.72 M(+14.2%) |
| Jun 2024 | - | -$70.77 M(+2.5%) | -$216.95 M(+28.8%) |
| Mar 2024 | - | -$69.06 M(+56.0%) | -$168.39 M(+21.0%) |
| Dec 2023 | -$139.21 M(-5.7%) | -$44.27 M(+34.8%) | -$139.21 M(+2.1%) |
| Sep 2023 | - | -$32.85 M(+47.9%) | -$136.40 M(-1.7%) |
| Jun 2023 | - | -$22.21 M(-44.3%) | -$138.69 M(-2.8%) |
| Mar 2023 | - | -$39.88 M(-3.8%) | -$142.63 M(-3.3%) |
| Dec 2022 | -$147.57 M(-0.8%) | -$41.45 M(+17.9%) | -$147.57 M(+0.1%) |
| Sep 2022 | - | -$35.15 M(+34.4%) | -$147.48 M(+4.3%) |
| Jun 2022 | - | -$26.14 M(-41.7%) | -$141.41 M(-1.6%) |
| Mar 2022 | - | -$44.82 M(+8.4%) | -$143.68 M(-3.4%) |
| Dec 2021 | -$148.78 M | -$41.36 M(+42.2%) | -$148.78 M(+9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$29.08 M(+2.4%) | -$135.75 M(+6.4%) |
| Jun 2021 | - | -$28.41 M(-43.1%) | -$127.58 M(+17.5%) |
| Mar 2021 | - | -$49.93 M(+76.3%) | -$108.57 M(+53.5%) |
| Dec 2020 | -$70.73 M(+14.5%) | -$28.32 M(+35.5%) | -$70.73 M(+7.3%) |
| Sep 2020 | - | -$20.91 M(+122.4%) | -$65.89 M(+26.4%) |
| Jun 2020 | - | -$9.40 M(-22.3%) | -$52.12 M(-28.7%) |
| Mar 2020 | - | -$12.09 M(-48.5%) | -$73.05 M(+18.3%) |
| Dec 2019 | -$61.76 M(+5937.1%) | -$23.49 M(+229.3%) | -$61.76 M(+61.4%) |
| Sep 2019 | - | -$7.13 M(-76.5%) | -$38.27 M(+22.9%) |
| Jun 2019 | - | -$30.33 M(+3658.2%) | -$31.14 M(+3758.2%) |
| Mar 2019 | - | -$807.00 K | -$807.00 K |
| Dec 2018 | -$1.02 M | - | - |
FAQ
- What is Phathom Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals annual FCF year-on-year change?
- What is Phathom Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals quarterly FCF year-on-year change?
- What is Phathom Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals TTM FCF year-on-year change?
What is Phathom Pharmaceuticals annual free cash flow?
The current annual FCF of PHAT is -$139.21 M
What is the all time high annual FCF for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high annual free cash flow is -$1.02 M
What is Phathom Pharmaceuticals annual FCF year-on-year change?
Over the past year, PHAT annual free cash flow has changed by +$8.36 M (+5.66%)
What is Phathom Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of PHAT is -$63.62 M
What is the all time high quarterly FCF for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high quarterly free cash flow is -$807.00 K
What is Phathom Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, PHAT quarterly free cash flow has changed by +$7.15 M (+10.10%)
What is Phathom Pharmaceuticals TTM free cash flow?
The current TTM FCF of PHAT is -$247.72 M
What is the all time high TTM FCF for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high TTM free cash flow is -$807.00 K
What is Phathom Pharmaceuticals TTM FCF year-on-year change?
Over the past year, PHAT TTM free cash flow has changed by -$30.76 M (-14.18%)